Mikhail Blagosklonny is a scientist who has an interest in cancer and aging. The research that he does mostly range in translating the current science into new anticancer strategies; he wants to find the answer to protecting normal cells by studying drug resistance and cancer cell cycling. He also does research on molecular, cellular biology and clinical investigations; including mitosis, apoptosis, tumor suppression and oncogenes. Rapamycin is a popular cancer drug that Dr. Blagosklonny revealed can be used as an anti-aging; following his research on aging he concluded that the drug could prolong life.
Mikhail Blagosklonny attained both his Doctor of Medicine in internal medicine and Ph.D. in Experimental Medicine and Cardiology at the First Pavlov State Medical University of St. Peterburg. Currently, he is an oncology professor at the Roswell Park Cancer Institute since 2009; he worked previously at the New York Medical College as an associate professor of medicine in 2002, then, he was a senior scientist at Ordway Research Institute.
Mikhail has a broad range of skills and expertise ranging from transitional medicine, chemoprevention, cancer biomarkers, protein kinases and many others, with all these it is difficult to deny that he is among the top scientists. Students at Roswell Park Cancer Institute have the privilege to learn from the best.
Apart from teaching and research Dr. Mikhail is the chief editor of Aging, Cell Cycle and Oncotarget, associate editor of Cancer Biology and Therapy and is also on the board of editors of Cell Death and Differentiation. In the peer review journals, Blagosklonny has published over two hundred and seventy papers and over twenty-five thousand citations. His publications are very informative and come in a lot of people have interest in them.
Dr. Mikhail Blagosklonny is considered to be very passionate about his research and it is the reason he has been given high position in cancer and aging-related reviews and institutions. With his kind of determination with time he will make significant steps that will assist cancer patients; maybe, something that world will be able to use so that cancer can be fought ones and for all. View his profile on LinkedIn.